No Data
Reviewing Corcept Therapeutics (NASDAQ:CORT) & Phibro Animal Health (NASDAQ:PAHC)
Phibro Animal Health (NASDAQ:PAHC – Get Rating) and Corcept Therapeutics (NASDAQ:CORT – Get Rating) are both medical companies, but which is the superior investment? We will contrast the two companie
Sector Update: Health Care Stocks Retreat Pre-Bell Friday
09:22 AM EDT, 09/23/2022 (MT Newswires) -- Health care stocks were retreating pre-bell Friday. The Health Care SPDR (XLV) was 0.80% lower and the iShares Biotechnology Index (IBB) was recently slippin
Corcept Extends Distribution Agreement for Cushing’s Syndrome Drug
Corcept Therapeutics Incorporated (NASDAQ:CORT), the maker of Cushing's syndrome medication Korlym, has extended its partnership with specialty pharmacy Optime Care, Inc., for U.S. distribution of the
Corcept Therapeutics Extends Pharmacy Deal With Optime Care for Hyperglycemia Drug
Corcept Therapeutics Extends Korlym Distribution Pact With Optime
Investors in Corcept Therapeutics (NASDAQ:CORT) Have Made a Respectable Return of 83% Over the Past Three Years
By buying an index fund, you can roughly match the market return with ease. But if you buy good businesses at attractive prices, your portfolio returns could exceed the average market return. For ex
Bragar Eagel & Squire, P.C. Is Investigating Corcept, Discover, Mercury, and Fulgent and Encourages Investors to Contact the Firm
Corcept Therapeutics Incorporated (NASDAQ:CORT) Insider Sells $1,303,000.00 in Stock
Corcept Therapeutics Incorporated (NASDAQ:CORT – Get Rating) insider Gary Charles Robb sold 50,000 shares of Corcept Therapeutics stock in a transaction on Wednesday, September 7th. The shares were s
Corcept Therapeutics Exec Sells $1.3M in Common Stock
In a regulatory filing, Corcept Therapeutics disclosed that its Chief Business Officer Gary Robb sold 50K share of common stock on September 7th in a total transaction size of $1.3M.
Corcept Therapeutics Incorporated's (NASDAQ:CORT) Insiders Who Sold Earlier This Year May Be Offered Solace in This Recent Price Drop
Even though Corcept Therapeutics Incorporated (NASDAQ:CORT) has fallen by 4.4% over the past week , insiders who sold US$1.8m worth of stock over the past year have had less luck. Given that the aver
Loading...
